Folgen
Mansoor M Amiji
Mansoor M Amiji
Northeastern University, Boston, Massachusetts
Bestätigte E-Mail-Adresse bei northeastern.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
A review of stimuli-responsive nanocarriers for drug and gene delivery
S Ganta, H Devalapally, A Shahiwala, M Amiji
Journal of controlled release 126 (3), 187-204, 2008
25452008
Chitosan-based gastrointestinal delivery systems
R Hejazi, M Amiji
Journal of controlled release 89 (2), 151-165, 2003
11982003
Poly (ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery
LE Van Vlerken, TK Vyas, MM Amiji
Pharmaceutical research 24, 1405-1414, 2007
8052007
Exosome mediated communication within the tumor microenvironment
L Milane, A Singh, G Mattheolabakis, M Suresh, MM Amiji
Journal of Controlled Release 219, 278-294, 2015
7512015
Biodegradable poly (ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
JS Chawla, MM Amiji
International journal of pharmaceutics 249 (1-2), 127-138, 2002
6442002
Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells
S Ganta, M Amiji
Molecular pharmaceutics 6 (3), 928-939, 2009
5962009
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
G Mattheolabakis, L Milane, A Singh, MM Amiji
Journal of drug targeting 23 (7-8), 605-618, 2015
5742015
Preparation and characterization of freeze-dried chitosan-poly (ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach
VR Patel, MM Amiji
Pharmaceutical research 13, 588-593, 1996
5481996
Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers
M Amiji, K Park
Biomaterials 13 (10), 682-692, 1992
5141992
Multi-functional nanocarriers to overcome tumor drug resistance
LS Jabr-Milane, LE van Vlerken, S Yadav, MM Amiji
Cancer treatment reviews 34 (7), 592-602, 2008
5082008
Poly (ethylene oxide)-modified poly (ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer
DB Shenoy, MM Amiji
International journal of pharmaceutics 293 (1-2), 261-270, 2005
4972005
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
LE Van Vlerken, MM Amiji
Expert opinion on drug delivery 3 (2), 205-216, 2006
4922006
Surface modification of polymeric biomaterials with poly (ethylene oxide), albumin, and heparin for reduced thrombogenicity
M Amiji, K Park
Journal of Biomaterials Science, Polymer Edition 4 (3), 217-234, 1993
4711993
Enzyme immobilization in novel alginate–chitosan core-shell microcapsules
E Taqieddin, M Amiji
Biomaterials 25 (10), 1937-1945, 2004
4262004
Technologies and standardization in research on extracellular vesicles
S Gandham, X Su, J Wood, AL Nocera, SC Alli, L Milane, A Zimmerman, ...
Trends in biotechnology 38 (10), 1066-1098, 2020
4042020
pH‐responsive polymer microspheres: Rapid release of encapsulated material within the range of intracellular pH
DM Lynn, MM Amiji, R Langer
Angewandte Chemie 113 (9), 1757-1760, 2001
3972001
Long-circulating poly (ethylene glycol)-modified gelatin nanoparticles for intracellular delivery
G Kaul, M Amiji
Pharmaceutical research 19, 1061-1067, 2002
3902002
Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices
E Gultepe, D Nagesha, S Sridhar, M Amiji
Advanced drug delivery reviews 62 (3), 305-315, 2010
3802010
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
S Ganesh, AK Iyer, DV Morrissey, MM Amiji
Biomaterials 34 (13), 3489-3502, 2013
3792013
Role of integrated cancer nanomedicine in overcoming drug resistance
AK Iyer, A Singh, S Ganta, MM Amiji
Advanced drug delivery reviews 65 (13-14), 1784-1802, 2013
3782013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20